Product Details for: Rezvoglar

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
300UNITS/3ML (100UNITS/ML)
Autoinjector
351(k) Interchangeable
Rezvoglar
Rx
Proper Name
insulin glargine-aglr
Reference Product Proper Name
insulin glargine
Reference Product Properietary Name
Lantus
BLA Number
761215
Applicant
Eli Lilly and Company
Original Approval Date
December 17, 2021
Date of First Licensure
RETURN TO SEARCH RESULTS